The pharmacological studies on methyl-eugenol
Jiang, Y.; Liu, G.Q.; Ma, J.R.; Xie, L.; Wu, H.Q.
Yao Xue Xue Bao 17(2): 87-92
1982
ISSN/ISBN: 0513-4870 PMID: 7102326 Document Number: 183906
Document emailed within 1 workday
Related Documents
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Oliver, W.M.; Heaney, T.G. 1970: Sequelae following the use of eugenol or non-eugenol dressings after gingivectomy and subgingival curettage Dental Practitioner and Dental Record 21(2): 49-52
Kubo, S.; Morikawa, K.; Matsubara, I.; Yamazaki, M.; Kato, H. 1981: Pharmacological studies of antispasmodics. III. Antispasmodic activity of 3-(di-2-thienylmethylene)-5-methyl-trans-quino-lizidinium bromide (HRS-902) on smooth muscle organs and its organ selectivity Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 77(1): 87-98
Kubo, S.; Uesaka, I.; Matsubara, I.; Ishihara, T.; Kasé, Y. 1977: Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. II. Actions on the cardio-vascular system and smooth muscle organs Arzneimittel-Forschung 27(7): 1433-1439
Romanovich, A.I.; Chizhov, O.S.; Sviridov, A.F. 1988: Synthetic studies in the series of polyene macrolide antibiotics. 5. Synthesis of methyl-2,4,6-trideoxy-2,4-di-C-methyl-alpha-L- gluco-hexopyranoside and methyl-2,4,6-trideoxy-2,4-di-C-methyl- alpha-L-manno-hexopyranoside, the stereoisomers of the C33-C38 fragment of amphotericin B Bioorganicheskaia Khimiia 14(8): 1109-1112
Nawrocka, W.; Rutkowska, M.; Szelag, A.; Barczyńska, J.; Kedzierska-Goździk, L.; Błaszczyk, F.; Dziwiszek, W. 1996: Synthesis and pharmacological properties of new derivatives of 4-methyl-5-oxalo-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2-one and beta-oxo-5-(4-methyl-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2 -one)propionic acid Acta Poloniae Pharmaceutica 53(6): 425-430
Pinna, G.A.; Curzu, M.M.; Barlocco, D.; Cignarella, G.; Cavalletti, E.; Germini, M.; Berger, K. 1988: Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones Il Farmaco; Edizione Scientifica 43(6): 539-549
Liao, J.F.; Chen, C.F.; Chow, S.Y. 1981: Pharmacological studies of Chinese herbs. (9) Pharmacological effects of Evodiae fructus Journal of the Formosan Medical Association 80(1): 30-38
Chow, S.Y.; Chen, C.F.; Chen, S.M. 1977: Pharmacological studies of Chinese herbs. (6) Pharmacological effects of Epiphyllum oxypetalum Haw Journal of the Formosan Medical Association 76(12): 916-925
Cybulska, B.; Kupczyk, K.; Szlinder-Richert, J.; Borowski, E. 2002: Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME) Acta Biochimica Polonica 49(1): 67-75
Ferkany, J.W.; Kyle, D.J.; Willets, J.; Rzeszotarski, W.J.; Guzewska, M.E.; Ellenberger, S.R.; Jones, S.M.; Sacaan, A.I.; Snell, L.D.; Borosky, S. 1989: Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist Journal of Pharmacology and Experimental Therapeutics 250(1): 100-109
Prado de Carvalho, L.; Venault, P.; Cavalheiro, E.; Kaijima, M.; Valin, A.; Dodd, R.H.; Potier, P.; Rossier, J.; Chapouthier, G. 1983: Distinct behavioral and pharmacological effects of two benzodiazepine antagonists: Ro 15-1788 and methyl beta-carboline Advances in Biochemical Psychopharmacology 38: 175-187
Eguchi, J.; Inomata, Y.; Yuasa, T.; Egawa, M.; Saito, K. 1997: Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride Arzneimittel-Forschung 47(12): 1337-1347
Schoepp, D.D.; Ornstein, P.L.; Leander, J.D.; Lodge, D.; Salhoff, C.R.; Zeman, S.; Zimmerman, D.M. 1990: Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action Journal of Pharmacology and Experimental Therapeutics 255(3): 1301-1308
Nakamura, H.; Yokoyama, Y.; Motoyoshi, S.; Ishii, K.; Imazu, C.; Seto, Y.; Kadokawa, T.; Shimizu, M. 1983: The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity Arzneimittel-Forschung 33(11): 1555-1569
Gambhir, S.S.; Sanyal, A.K.; Sen, S.P.; Das, P.K. 1966: Studies on Daucus carota, Linn. I. Pharmacological studies with the water-soluble fraction of the alcoholic extract of the seeds: a preliminary report Indian Journal of Medical Research 54(2): 178-187
Dilov, P.; Antonov, S.; Chakŭrov, R.; Petkov, R.; Gabrovski, P. 1984: Dextrofer-100 with B12 and dextrofer-100--comparative pharmacological and clinico-pharmacological studies Veterinarno-Meditsinski Nauki 21(6): 91-100
Jackson, C.V.; Crowe, V.G.; Frank, J.D.; Wilson, H.C.; Coffman, W.J.; Utterback, B.G.; Jakubowski, J.A.; Smith, G.F. 1992: Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis Journal of Pharmacology and Experimental Therapeutics 261(2): 546-552
Priestley, T.; Laughton, P.; Myers, J.; Le Bourdellés, B.; Kerby, J.; Whiting, P.J. 1995: Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells Molecular Pharmacology 48(5): 841-848